Spinosin, a C-Glucosylflavone, from Zizyphus jujuba var. spinosa Ameliorates Aβ1–42 Oligomer-Induced Memory Impairment in Mice
| Autor: | Se Jin Park, Dae Sik Jang, Jong Hoon Ryu, Qingtao Gao, Boseong Kim, Hyung Eun Lee, Sang Yoon Ko, Se Jin Jeon |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Pharmacology
Pathology medicine.medical_specialty Programmed cell death Amyloid-β oligomer Microglia Amyloid medicine.diagnostic_test business.industry Biochemistry Choline acetyltransferase Neuroprotection Spinosin medicine.anatomical_structure Western blot Drug Discovery medicine Molecular Medicine Memory impairment Immunohistochemistry Original Article business Alzheimer’s disease |
| Zdroj: | Biomolecules & Therapeutics |
| ISSN: | 1976-9148 2005-4483 |
| DOI: | 10.4062/biomolther.2014.110 |
| Popis: | Alzheimer’s disease (AD) is a neurodegenerative disorder associated with progressive memory loss and neuronal cell death. Although numerous previous studies have been focused on disease progression or reverse pathological symptoms, therapeutic strategies for AD are limited. Alternatively, the identification of traditional herbal medicines or their active compounds has received much attention. The aims of the present study were to characterize the ameliorating effects of spinosin, a C-glucosylflavone isolated from Zizyphus jujuba var. spinosa, on memory impairment or the pathological changes induced through amyloid-β1–42 oligomer (AβO) in mice. Memory impairment was induced by intracerebroventricular injection of AβO (50 μM) and spinosin (5, 10, and 20 mg/kg) was administered for 7 days. In the behavioral tasks, the subchronic administration of spinosin (20 mg/kg, p.o.) significantly ameliorated AβO-induced cognitive impairment in the passive avoidance task or the Y-maze task. To identify the effects of spinosin on the pathological changes induced through AβO, immunohistochemistry and Western blot analyses were performed. Spinosin treatment also reduced the number of activated microglia and astrocytes observed after AβO injection. In addition, spinosin rescued the AβO-induced decrease in choline acetyltransferase expression levels. These results suggest that spinosin ameliorated memory impairment induced through AβO, and these effects were regulated, in part, through neuroprotective activity via the anti-inflammatory effects of spinosin. Therefore, spinosin might be a useful agent against the amyloid b protein-induced cognitive dysfunction observed in AD patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|